The photoswitchable cannabinoid <i>azo</i> ‐ <scp>HU308</scp> enables optical control of Ca <sup>2+</sup> dynamics in <scp>INS</scp> ‐1 β‐cells via off‐target effects on <scp>TRPC</scp> channels

Intracellular Ca<sup>2+</sup> regulates insulin secretion from pancreatic β-cells and is influenced by cannabinoid signaling. However, the hydrophobicity and complex pharmacology of cannabinoid ligands prevent precision receptor targeting, limiting our understanding of their roles in modulating insulin release. Here, we use fluorescent Ca<sup>2+</sup> imaging to examine how the light-activatable CB2 receptor agonist azo-HU308 modulates Ca<sup>2+</sup> dynamics in INS-1 β-cells. UV-A photoactivation of azo-HU308 triggered robust, repeatable Ca<sup>2+</sup> transients, and pharmacological profiling revealed this effect was independent of CB2 receptor activation but was instead mediated by extracellular Ca<sup>2+</sup> influx through TRPC channels. These findings position azo-HU308 as a novel optical tool for controlling β-cell Ca<sup>2+</sup> levels and highlight a non-GPCR pathway by which synthetic cannabinoids can modulate Ca<sup>2+</sup> dynamics in excitable cells.

Authors

Institutions

Publication Details

Journal
FEBS Open Bio
Published
2025-11-02
DOI
https://doi.org/10.1002/2211-5463.70146
Primary Topic
Pancreatic function and diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The photoswitchable cannabinoid azo ‐ HU308 enables optical control of Ca 2+ dynamics in INS ‐1 β‐cells via off‐target effects on TRPC channels

Alexander E. G. Viray, James A. Frank
FEBS Open Bio
Pancreatic function and diabetes
article

The photoswitchable cannabinoid azo ‐ HU308 enables optical control of Ca 2+ dynamics in INS ‐1 β‐cells via off‐target effects on TRPC channels

Alexander E. G. Viray, James A. Frank
article en

Abstract

Intracellular Ca<sup>2+</sup> regulates insulin secretion from pancreatic β-cells and is influenced by cannabinoid signaling. However, the hydrophobicity and complex pharmacology of cannabinoid ligands prevent precision receptor targeting, limiting our understanding of their roles in modulating insulin release. Here, we use fluorescent Ca<sup>2+</sup> imaging to examine how the light-activatable CB2 receptor agonist azo-HU308 modulates Ca<sup>2+</sup> dynamics in INS-1 β-cells. UV-A photoactivation of azo-HU308 triggered robust, repeatable Ca<sup>2+</sup> transients, and pharmacological profiling revealed this effect was independent of CB2 receptor activation but was instead mediated by extracellular Ca<sup>2+</sup> influx through TRPC channels. These findings position azo-HU308 as a novel optical tool for controlling β-cell Ca<sup>2+</sup> levels and highlight a non-GPCR pathway by which synthetic cannabinoids can modulate Ca<sup>2+</sup> dynamics in excitable cells.

FEBS Open BioVol. 16(3)
Oregon Health & Science University (US), Vollum Institute (US)
Openalex Percentile: Top 50%
Pancreatic function and diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.